Harout Semerjian
Director Ejecutivo en GLYCOMIMETICS, INC. .
Fortuna: 42 750 $ al 30/04/2024
Cargos activos de Harout Semerjian
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| GLYCOMIMETICS, INC. | Director/Miembro de la Junta | 06/08/2021 | - |
| Director Ejecutivo | 06/08/2021 | - | |
| Presidente | 06/08/2021 | - |
Historial de carrera de Harout Semerjian
Antiguos cargos conocidos de Harout Semerjian.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| IMMUNOMEDICS, INC. | Director/Miembro de la Junta | 16/04/2020 | 27/05/2020 |
| Director Ejecutivo | 16/04/2020 | 27/05/2020 | |
| Presidente | 16/04/2020 | 27/05/2020 | |
| IPSEN | Corporate Officer/Principal | 01/03/2018 | 01/04/2020 |
Ipsen Pharma SAS
 Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Ipsen Pharma SAS is a biopharmaceutical company that develops medicines in oncology, neuroscience and rare diseases. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France. | Corporate Officer/Principal | - | - |
Formación de Harout Semerjian.
| Cornell University | Masters Business Admin |
| Queen's University | Masters Business Admin |
| Lebanese American University | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 4 |
| Francia | 3 |
| Canadá | 2 |
Operativa
| Corporate Officer/Principal | 2 |
| Director/Board Member | 2 |
| Chief Executive Officer | 2 |
Sectorial
| Health Technology | 5 |
| Consumer Services | 4 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| IPSEN | Health Technology |
| GLYCOMIMETICS, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Ipsen Pharma SAS
Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Ipsen Pharma SAS is a biopharmaceutical company that develops medicines in oncology, neuroscience and rare diseases. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France. | Health Technology |
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Immunomedics, Inc. researching, developing, manufacturing, and marketing biopharmaceutical products. It focuses on monoclonal antibody-based products for the targeted treatment of cancer. The company was founded by David M. Goldenberg in July 1982 and is headquartered in Morris Plains, NJ. | Health Technology |
- Bolsa de valores
- Insiders
- Harout Semerjian
- Experiencia
